President Trump Announces TrumpRx Website for Cheaper Drugs with Pfizer Deal
President Trump has announced a new deal with Pfizer to sell its medicines directly to people at lower prices. The drugs will be offered on a new government website called TrumpRx.gov, expected to launch in 2026.
At the White House, Trump met with Pfizer CEO Albert Bourla and other top health officials to share the news. Trump said more deals with other drug companies may come soon.

Francis Chung/Politico/Bloomberg via Getty Images – Source
What is TrumpRx.gov?
- It will be a federal website where people can buy Pfizer medicines at lower prices.
- On average, Pfizer drugs will cost 50% less when bought through this site.
- The plan is to make U.S. drug prices similar to those in other wealthy countries.
Who Can Use It?
The discount is only for patients paying without insurance.
- If you use insurance, you may already pay less at the pharmacy.
- The site may not help everyone, since discounts are based on the high list prices of drugs.
Experts warn many patients may not see real savings.
Why Is This Happening?
In many countries, governments set drug prices. That keeps them lower.
In the U.S., companies can charge whatever the market accepts.
Trump said Americans have been paying more than other nations, which is unfair.
Pfizer agreed to:
- Sell new drugs at the same price in the U.S. and other developed countries.
- Offer Medicaid patients most-favored-nation pricing (the lowest rate offered elsewhere).
Experts React
Some experts say the plan may not help much:
- Ameet Sarpatwari from Harvard Medical School said the deal feels like “window dressing” and won’t solve high drug costs.
- He pointed out that Medicaid already pays low prices, so the impact may be small.

Pfizer’s headquarters in New York, US [File: Mark Lennihan/AP Photo] – Source
Trump’s Push on Drug Prices
- Earlier this year, Trump signed an executive order to cut drug costs.
- His administration warned 17 drugmakers to lower prices or face tariffs.
- Pfizer’s deal gives it a three-year break from tariffs.
- Pfizer also promised to invest $70 billion to bring more drug manufacturing back to the U.S.
Pfizer’s Bourla praised the agreement, saying it sets an example for other companies. Trump’s team called it a step toward fairer global pricing.
✅ Key Takeaways
- TrumpRx.gov will launch in 2026 for cheaper Pfizer drugs.
- Discounts may not help everyone, especially those with insurance.
- Experts question if this deal will truly lower costs for most Americans.
- Pfizer gains tariff relief and plans major U.S. investment.
🔗 Source: Read the full NPR report here